Document is current
Any future updates will be listed below
-
Authors
van der Hout, A.
Jansen, F.
van Uden-Kraan, C. F.
Coupé, V. M.
Holtmaat, K.
Nieuwenhuijzen, G. A.
Hardillo, J. A.
de Jong, R. J. Baatenburg
Tiren-Verbeet, N. L.
Sommeijer, D. W.
de Heer, K.
Schaar, C. G.
Sedee, R. J. E.
Bosscha, K.
van den Brekel, M. W. M.
Petersen, J. F.
Westerman, M.
Honings, J.
Takes, R. P.
Houtenbos, I.
van den Broek, W. T.
de Bree, R.
Jansen, P.
Eerenstein, S. E. J.
Leemans, C. R.
Zijlstra, J. M.
Cuijpers, P.
van de Poll-Franse, L. V.
Verdonck-de Leeuw, I. M. https://orcid.org/0000-0002-4507-4607
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding (VU 2014-7202)
- License Information
-
More Information
Article History
Received: 10 March 2020
Accepted: 26 June 2020
First Online: 12 July 2020
Compliance with ethical standards
:
: IMV-dL has received grants from the Dutch Cancer Society (KWF Kankerbestrijding), Pink Ribbon, the Netherlands Organization for Health Research and Development (ZonMW), the SAG Foundation–Zilveren Kruis Health Care Assurance Company, Danone Ecofund–Nutricia, Red-kite (distributor of eHealth tools), and Bristol-Myers Squibb, during the conduct of this study. CRL has received personal fees for global advisory board participation from MSD, during the conduct of this study. All other authors have no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: This article does not contain any studies with animals performed by any of the authors.
: Informed consent was obtained from all individual participants included in the study.
